Trademark: IMMUNOGENIX XL
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for IMMUNOGENIX XL
We do not have any records of a proof of use for IMMUNOGENIX XL at this moment.
Possible trademark infringements of IMMUNOGENIX XL
Basic Information about IMMUNOGENIX XL
- Serial Number
- 97031692
- Filing Date
- 16 Sep 2021
- Registration Number
- 7045985
- Registration Date
- 09 May 2023
- Mark Drawing Code
- 5
Classifications
Declare the trademark use of IMMUNOGENIX XL on the blockchain with WikiTrademarks.io.
- First use of IMMUNOGENIX XL anywhere
- IMMUNOGENIX XL was first used on 11 Jun 2020 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns IMMUNOGENIX XL?
1. Centinela Medical Center of South Bay Inc. Lawndale CA
2. Centinela Medical Center of South Bay Inc. Lawndale CA
3. Centinela Medical Center of South Bay Inc. Lawndale CA
Correspondent
- Centinela Medical Center of South Bay In
- 15901 Hawthorne Blvd STE 450
- Lawndale, CA 90260
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io